Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Deferred Taxes (2021 - 2023)

Oncology Institute posted quarterly Deferred Taxes of -$126000.0 for Q4 2023, up 71.75% year-on-year from -$73362.9 in Q4 2022, and down 257.5% on a QoQ basis from $80000.0 in Q3 2023.

Oncology Institute (DFPH) has 3 years of Deferred Taxes data on file, last reported at -$126000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Deferred Taxes rose 71.75% year-over-year to -$126000.0; the trailing twelve-month figure through Sep 2024 stood at -$126000.0 (up 68.18% YoY), and the FY2025 full-year result was -$32000.0, changed N/A from the prior year.
  • Deferred Taxes for Q4 2023 stood at -$126000.0, down from $80000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $2.3 million in Q4 2021 and bottomed at -$3.8 million in Q3 2021.
  • The 3-year median for Deferred Taxes is -$4000.0 (2023), against an average of -$143727.3.
  • Peak annual rise in Deferred Taxes reached 101.38% in 2022, while the deepest fall reached 119.43% in 2022.
  • A 3-year view of Deferred Taxes shows it stood at $2.3 million in 2021, then tumbled by 119.43% to -$446000.0 in 2022, then surged by 71.75% to -$126000.0 in 2023.
  • The last three Deferred Taxes figures came in at -$126000.0 (Q4 2023), $80000.0 (Q3 2023), and -$4000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 435.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -40.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 54.80 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 8.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -104.77 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 3.89 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -4.74 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -12.46 Mn
10 Oncology Institute - - 139.16 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -126,000.00
Sep 30, 2023 80,000.00
Jun 30, 2023 -4,000.00
Mar 31, 2023 -26,000.00
Dec 31, 2022 -446,000.00
Sep 30, 2022 52,000.00
Jun 30, 2022 -49,000.00
Mar 31, 2022 180,000.00
Dec 31, 2021 2.30 Mn
Sep 30, 2021 -3.76 Mn
Mar 31, 2021 221,000.00